Why the answer is hemodialysisHyperkalemia management follows a three-step sequence: first stabilize the myocardium with calcium, then shift potassium into cells with insulin plus dextrose or a beta-2 agonist, and finally remove potassium from the body. In this patient, calcium gluconate and insulin with dextrose were already given and the ECG normalized, but the potassium remained at
6.8 mEq/L two hours later. That means the shifting step did not lower the serum level enough, and the definitive removal step is now required.
In an anuric patient, potassium cannot be excreted through the kidneys, so a loop diuretic such as furosemide is ineffective. The bladder scan was empty, urine output has been minimal, and the patient has now passed no urine for 8 hours despite a normal blood pressure. This is not a prerenal volume problem that diuresis can fix; the kidney is not making urine. Therefore furosemide cannot remove potassium.
A second dose of calcium gluconate would only re-stabilize the cardiac membrane. It does not lower serum potassium at all. Salbutamol by nebulizer would shift potassium into cells temporarily, but the potassium has already proven refractory to a shifting strategy, and shifting does not remove potassium from the body.
Key point! Calcium protects the heart; it never removes potassium. Insulin, dextrose, and salbutamol move potassium into cells; they do not eliminate it.
Refractory hyperkalemia with kidney failure and anuria is an indication for kidney replacement therapy. Hemodialysis through a temporary dialysis catheter directly removes potassium from the blood and is the definitive treatment when shifting measures fail and urine output is absent. The ISPD guideline supports dialysis as a suitable modality for AKI when kidney function is inadequate to manage metabolic complications such as severe hyperkalemia
[1]. In low-resource and high-resource settings alike, kidney replacement therapy is a cornerstone of supportive care for severe AKI when life-threatening electrolyte abnormalities cannot be controlled by medical management alone
[2].
Why this AKI is likely intrinsic, not prerenalThe patient had a hypotensive episode on the day of surgery with a systolic pressure around
82 mmHg for about 20 minutes. That degree of hypotension can reduce renal perfusion enough to cause acute tubular injury, even after blood pressure is restored. The preoperative creatinine was
1.0 mg/dL, and it has risen to
1.8 mg/dL by post-operative day 2. The BUN is also elevated at
46 mg/dL. The urine output of
22 mL/h over 14 hours is oliguric for a 60 kg adult, and by post-operative day 4 the patient is anuric. This pattern of rising creatinine with oliguria progressing to anuria after a hypotensive insult is consistent with acute tubular injury rather than simple dehydration. AKI is increasingly understood as a systemic syndrome in which the injured kidney cannot clear metabolites and electrolytes, leading to complications beyond the kidney itself, including hyperkalemia and cardiac dysrhythmia .
Why potassium is so dangerous hereA potassium of
6.8 mEq/L is a life-threatening emergency because the resting membrane potential of cardiac cells becomes less negative, making them more excitable initially and then paradoxically depressed. Peaked T waves are the earliest ECG sign. If untreated, this can progress to widened QRS, sine wave, ventricular fibrillation, or asystole. Calcium gluconate works within minutes to stabilize the cardiac membrane, but its effect lasts only 30 to 60 minutes and it does not change the serum potassium. Insulin with dextrose shifts potassium into cells within 15 to 30 minutes, but the effect also wears off. When the potassium remains at
6.8 mEq/L after these measures, the potassium burden is too large for temporary shifting to control, and removal is mandatory.
Comparing the options| Intervention | Mechanism | Can it remove potassium in anuria? | Role in this case |
|---|
| Furosemide IV | Inhibits Na-K-2Cl cotransporter in thick ascending limb; increases urinary potassium excretion | No; requires urine output | Ineffective because the patient is anuric |
| Calcium gluconate repeat | Stabilizes cardiac membrane; no effect on serum potassium | No; does not remove or shift potassium | Only for ECG protection; potassium unchanged |
| Salbutamol nebulized | Beta-2 agonist; shifts potassium into cells via Na-K ATPase | No; temporary shift only | May lower potassium briefly but does not eliminate it |
| Hemodialysis | Removes potassium across a semipermeable membrane | Yes; independent of urine output | Definitive treatment for refractory hyperkalemia in AKI |
Watch out! Do not confuse membrane stabilization with potassium removal. Calcium gluconate is given first when ECG changes are present, but it is not a treatment for the potassium level itself.
Key point! The sequence is stabilize, shift, remove. When shifting fails and the patient is anuric, removal by dialysis is the only effective option.
References (research sources)
- [1]
ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults).GuidelineCullis B, Al-Hwiesh A, Kilonzo K, McCulloch M, Niang A, Nourse P (2021) · DOI: 10.1177/0896860820970834
- [2]
Kidney replacement therapy for acute kidney injury in low-resource settings: Lessons from Africa.Research articleAbdelhamid YM, Fayed A, Mayamba Nlandu Y, Ghosh S. (2026) · DOI: 10.5527/wjn.122148